Regent Peak Wealth Advisors LLC Sells 817 Shares of Oracle Co. (NYSE:ORCL)

Regent Peak Wealth Advisors LLC decreased its holdings in Oracle Co. (NYSE:ORCL) by 8.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,617 shares of the enterprise software provider’s stock after selling 817 shares during the period. Regent Peak Wealth Advisors LLC’s holdings in Oracle were worth $1,205,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Capital & Planning LLC boosted its stake in shares of Oracle by 0.5% in the 4th quarter. Capital & Planning LLC now owns 15,727 shares of the enterprise software provider’s stock worth $2,621,000 after buying an additional 81 shares during the last quarter. Brighton Jones LLC boosted its stake in shares of Oracle by 189.3% in the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock worth $25,593,000 after buying an additional 100,494 shares during the last quarter. Union Bancaire Privee UBP SA purchased a new position in shares of Oracle in the 4th quarter worth $51,084,000. Revolve Wealth Partners LLC boosted its stake in shares of Oracle by 8.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock worth $903,000 after buying an additional 404 shares during the last quarter. Finally, Financial Advocates Investment Management boosted its stake in shares of Oracle by 10.5% in the 4th quarter. Financial Advocates Investment Management now owns 6,787 shares of the enterprise software provider’s stock worth $1,131,000 after buying an additional 646 shares during the last quarter. Institutional investors own 42.44% of the company’s stock.

Oracle Trading Up 1.8%

ORCL opened at $174.22 on Friday. The stock has a market cap of $487.29 billion, a price-to-earnings ratio of 42.60, a P/E/G ratio of 3.46 and a beta of 1.32. The stock’s 50 day moving average price is $147.20 and its 200-day moving average price is $160.46. Oracle Co. has a one year low of $118.86 and a one year high of $198.31. The company has a debt-to-equity ratio of 5.65, a quick ratio of 0.81 and a current ratio of 0.81.

Oracle (NYSE:ORCL) last released its earnings results on Monday, March 10th. The enterprise software provider reported $1.47 EPS for the quarter, missing analysts’ consensus estimates of $1.49 by ($0.02). The business had revenue of $14.13 billion for the quarter, compared to the consensus estimate of $14.40 billion. Oracle had a net margin of 21.16% and a return on equity of 133.25%. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the company posted $1.41 EPS. On average, equities analysts forecast that Oracle Co. will post 5 EPS for the current year.

Oracle Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 23rd. Investors of record on Thursday, April 10th were issued a $0.50 dividend. This is a positive change from Oracle’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Thursday, April 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.15%. Oracle’s payout ratio is presently 46.95%.

Analyst Ratings Changes

ORCL has been the topic of several analyst reports. Piper Sandler reiterated a “neutral” rating and set a $130.00 target price (down from $190.00) on shares of Oracle in a research report on Wednesday, April 23rd. Jefferies Financial Group lowered their target price on Oracle from $220.00 to $190.00 and set a “buy” rating on the stock in a research report on Monday, March 31st. Mizuho lowered their target price on Oracle from $210.00 to $180.00 and set an “outperform” rating on the stock in a research report on Tuesday, April 15th. Wall Street Zen downgraded Oracle from a “buy” rating to a “hold” rating in a research report on Wednesday, February 19th. Finally, Evercore ISI lowered their target price on Oracle from $200.00 to $185.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 11th. Fourteen investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $174.42.

Insider Activity at Oracle

In other Oracle news, Director Leon E. Panetta sold 5,000 shares of the stock in a transaction on Friday, April 11th. The stock was sold at an average price of $129.77, for a total transaction of $648,850.00. Following the sale, the director now owns 58,090 shares of the company’s stock, valued at approximately $7,538,339.30. This trade represents a 7.93% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Naomi O. Seligman sold 2,866 shares of the stock in a transaction on Monday, May 5th. The shares were sold at an average price of $149.53, for a total value of $428,552.98. Following the sale, the director now directly owns 31,764 shares in the company, valued at $4,749,670.92. This trade represents a 8.28% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 27,366 shares of company stock worth $4,015,723. Company insiders own 42.20% of the company’s stock.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.